Volume : 11, Issue : 04, April – 2024
Title:
REGULATORY REQUIREMENTS OF REGISTRATION OF GENERIC DRUGS IN USA
Authors :
Malinedi Gowthami*, G Ramakrishna, M. V. Nagabhushanam, Rompicharla Sushma, Tanniru Siva Pavani, Adilakshmi Challa
Abstract :
A generic drug is more efficient, safe and low-cost alternative of the innovator or branded drug in the market. They are similar to the branded drugs in strength, quality, purity and their safety and efficacy have been proven since they have been in the market for a longer time. The availability of generic medicine should be made easier throughout the world. The US has one of the most demanding regulatory authorities and registration of drug products will be a long process if not complied with the US Food and Drug Administration (USFDA) guidelines. Abbreviated New Drug Application is the application to be filed for registering generic drug. One of the main tasks of the regulatory authorities is to ensure that the drug development, manufacture and testing has been carried out according to the regulations and guidelines and that everything is documented accordingly. International Conference on Harmonization (ICH) established a harmonized format for submission of application on registering drug products.
Keywords: Generic Drug, Abbreviated New Drug Application (ANDA), US Food and Drug Administration (USFDA) guidelines.
Cite This Article:
Please cite this article in press Malinedi Gowthami et al, Regulatory Requirements Of Registration Of Generic Drugs In USA.,Indo Am. J. P. Sci, 2024; 11 (4).
Number of Downloads : 10
References:
1. United States Food and Drug Administration. Available from: http://www.fda. gov/About FDA/Centers Offices/de fault.html [accessed 13.11. 2017].
2. Dylst P, Vulto A, Simoens S. Overcoming challenges in market access of generic medicines in the European Union. Journal of Generic Medicines. 2012;9(1):21-8.
3. Hassali M et al. Physicians’ views on generic medicines: a narrative review. Journal of Generic Medicines. 2010;7(1):30-9.
4. “Generic Drugs”, U.S. Food and Drug Administration. Available from: http://en.wikipedia.org/wiki/U.S._Food_and_Drug_Administration [accessed23.11.2017].
5. Generic drug. Available from: http://en.wikipedia.org/wiki/Generic_drug#cite_ note-0. [Accessed 28.11. 2017].
6. Abbreviated New Drug Application (ANDA): Generics. Available from: http:// www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDeveloped and Approved/Approval Applications/Abbreviated New Drug Application ANDA Generics. [Accessed 28.11.17].
7. Brahmaiah Bonthagarala, Regulatory Requirements for Registration of Generic Drugs in “BRICS” Countries, International Journal of Pharmaceutical Science and Health Care, ISSN 2249 – 5738, Issue 6, Vol. 6 (November-December 2016), 20-39.
8. Brahmaiah Bonthagarala,Current Regulatory Requirements for Registration of Medicines, Compilation and Submission of Dossier in Australian Therapeutic Goods Administration, International Journal of Advanced Scientific and Technical Research, ISSN 2249-9954, Issue 6 volume 6, November-December 2016, 144-157.
9. Brahmaiah Bonthagarala,Comparison of Regulatory Requirements for Generic Drugs Dossier Submission in United States and Canada, International Journal of Pharmaceutical Science and Health Care, ISSN 2249 – 5738, Issue 6, Vol. 6 (November-December 2016), 1-19.
10. Brahmaiah Bonthagarala, Regulatory Requirements for Marketing of Generic Drugs in USA,International Journal of Pharmaceutical Research and Bio-Science, ISSN: 2277-8713, IJPRBS, 2017; Volume 6(2): 178-195.
11. Brahmaiah Bonthagarala,Guidelines for bioavailability and bioequivalence studies: A Review, The Pharma Innovation Journal 2018; 7(7): 661-666, ISSN (E): 2277- 7695.
12. Brahmaiah Bonthagarala,Generic Drug Registration and Regulatory Requirements in European Countries,World Journal of Pharmaceutical Research, 2018, Volume 7, Issue 16, 800-815.
13. KumarB.ComparisonofRegulatoryRequirementsForGenericDrugsDossierInUnitedStatesAndEurope.JournalofPharmaResearch.2019;8(8).
14. Abbreviated New Drug Application (ANDA) Available FromHttps://Www.Fda.Gov/Drugs/Types-Applications/Abbreviated-New-Drug-Application-Anda